Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NASDAQ2020 needs to remove Methotrexate from his list.
Methotrexate is the name of the undisclosed antimetabolite!!!!!..........LOL!!!!!
It was supposed to be approved in February but received a CRL.
The BE study date, BE press release, ANDA filing date, drug class, IQVIA, all line up in sync!!!!!
This is the undisclosed antimetabolite that was supposed to be approved in February.
Elite Pharmaceuticals Files ANDA With US FDA To Market Antimetabolite Product
NORTHVALE, NJ / April 20, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced that it filed an Abbreviated New Drug Application (ANDA) with the US Food and Drug Administration (FDA) for an undisclosed generic drug product in a class of medications called antimetabolites. IQVIA reported annual sales for the twelve months ending December 2022 of $42 million for the generic market for this product.
********** NEW **********
Drug: Methotrexate Tablets 2.5 mg
Sponsor: Elite Pharmaceuticals
Location: India
Status: Completed
Study: A multicenter, randomized, open label, two treatment, two period, two sequence, single-dose, crossover, bioequivalence study of Methotrexate Tablets 2.5 mg (manufactured by Elite Pharmaceuticals) with Methotrexate Tablets 2.5 mg (Distributed by West-Ward Pharmaceuticals Corp. Eatontown, NJ 07724) in patients with Rheumatoid Arthritis (RA), who are already on established regimens of 2.5 mg every 12 hours under fasting condition.
Market Size: (As of December 31, 2020) - According to IQVIA data, the total sales of Methotrexate Tablets in the US were approximately USD 80 million for the 12 months ended December 31, 2020.
FULL DETAILS: Click on links below. (May take a little while to load)
https://ctri.nic.in/Clinicaltrials/pmaindet2.php?EncHid=NzI1OTQ=&Enc=&userName=elite
PDF version: https://ctri.nic.in/Clinicaltrials/pdf_generate.php
----------------------------------------------------------------------------------------------------------------------------
Yeah, real smart.....
Sell Elite when it's low and buy gold when it's high.
You LITERALLY did the EXACT opposite of what you're supposed to be doing.
Both the Dopamine Agonist and Antimetabolite received CRL's.
I'm not sure what you're trying to argue.
Nasrat has been the CEO of Elite for nearly 11 years.
He has NEVER received an ANDA approval on the first submission.
What the HELL is wrong with him and his team???????!!!!!!!!!!!!!!!
A minor amendment is a 3-month review.
A major amendment is the full 10-month review again.
We don't know which ones they received.
BUT, you actually have to FIX the problem before we refile which could take SEVERAL months.
Read the following quote especially the last sentence. What a POS.
Nasrat: "The second ANDA, the antimetabolite ANDA, the FDA is very interested in that because that product is on product shortage. So the FDA is working very closely with us to ensure that it does get approved by the PDUFA date, which is February or before."
Both the Dopamine Agonist and Antimetabolite received CRL's.
Nasrat DUPED everyone on the November 2023 Conference Call when he implied the Antimetabolite would be approved on or even before February 2024. He stated the FDA was working closely with them to get it approved.
Nasrat is such a POS.
Elite has NEVER received an ANDA approval on the first try.
The ONLY time Elite received and ANDA approval on the first try was the Adderall IR............because it was CO-DEVELOPED and FILED by SunGen, NOT because Elite had anything to do with it.
This is why I LAUGH at everyone thinking we're going to be bought in 22 months.
Are shareholders THAT dumb they don't know Generic OxyContin AND Generic Vyvanse are ALSO going to receive CRL's because that is Elite's track record?
The 10-month ANDA review cycle starts ALL OVER after Elite receives a CRL.........and that is AFTER they fix the problem which could take 3-6 months.
So you have to add 13-16 months onto the buyout timeline stated in the last Conference Call.
***** NEW *****
Date: 04/01/2024
Drug Name: Adderall XR
Company: ELITE LABS INC
Submission status: Labeling Approval
The Form 4 and 10-K are both correct.
10-K - Nasrat Hakim - 295,824,820 shares - 29.1%
- "Includes 167,114,882 shares of Common Stock held and 49,701,277 shares of Common Stock due and owing to Mr. Hakim as of March 31, 2023 (the latest practicable date) for compensation earned pursuant to Mr. Hakim’s employment agreement with the Company and 79,008,661 shares of Common Stock issuable upon cash exercise of the Series J Warrants with an exercise price of $0.1521 per share."
I CAN'T believe how black and white this is.
This is a slam dunk case for any lawyer.
Why didn't Nasrat have Elite ITSELF purchase trimipramine for pennies on the dollar?
We all know why...
Nasrat is one corrupt MOTHER PHUCKER.
Don't we need to file the lawsuit right now against Mikah/Nasrat because of the statute of limitations?
Or is it already too late as far as his corruption in 2016 and 2017?
What the PHUCK does that have to do with anything?
LOOK at the timeline.
Has NOTHING to do with Adderall.
Holy sh*t!!!!! - Nasrat is going to JAIL!!!!! - Or a least a HUGE fine!!!!! (Class Action Lawsuit)
I didn't realize this was RIGHT in the middle of Mikah having "ceased operating" and also "winding down and LIQUIDATING its assets".
LOOK AT THIS TIMELINE:
2015 10-K - "Mikah has accordingly ceased operating and is in the process of winding down and liquidating its assets."
2016 10-K - "Mikah has accordingly ceased operating and is in the process of winding down and liquidating its assets."
2016 - While Hakim was CEO of Elite in 2016, Mikah purchased trimipramine ANDA from TEVA divestiture.
2017 10-K - "Mikah has accordingly ceased operating and is in the process of winding down and liquidating its assets."
2017 - Mikah made supply & distribution agreements with Epic & Dr. Reddy - all of it while telling Elite shareholders that Mikah was dead. Two weeks after signing the distribution agreement with Dr. Reddy, Mikah sold it to Elite for $1.2M plus interest.
2018 10-K - "Mikah has accordingly ceased operating and is in the process of winding down and liquidating its assets."
Even DSherman now admits Nasrat is corrupt and is lying to us.
He also just INADVERTENTLY admitted that WeeZuhl is right!
You're speaking out both sides of your mouth.
1. Recently you stated Nasrat did everything within the law and SEC rules and that he's completely honest.
2. Now you JUST admitted Nasrat is QUOTE "flat out lying to shareholders" by stating "welcome to pennyland".
WTF!!!!!!!!!!!!!!!!!!!!!!!!!!!!?????????????????????????
Press release postponed.
I see that it's raining in Northvale with a small chance of flurries as well.
Need the weather to clear up.
2017 - Nasrat: "We WILL being going to Nasdaq in a couple of years and we WILL be going to Dollar Land around that time within a couple of years."
You don't believe in Elite.
That 20 grand would have ALREADY been in ELTP if you thought they were going to succeed.
And that extra 50 grand is because you SOLD ELTP recently - because you don't believe.
TOTAL FRAUD.
Why didn't Nasrat lend the money to Elite at an agreed upon interest rate to buy the Adderalls...........just like he lent money to Elite when becoming CEO and just like he lent money to Elite last year?????
Okay, let's say Nasrat made a mistake by not lending the money to Elite to buy the Adderalls.
So let's just get an answer to a simple question then.
Previous conference call:
Question: "Hey Nasrat, how much did you pay for the Adderalls?"
Nasrat: "Shhh....🤫....Mikah is a private company."
Awfully quiet after this post:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173917015
Lol.
7 hours. (One of the two below)
You haven't been reading my posts?
It makes perfect sense: No Nasdaq, No Proper Valuation
WRONG.
10K - "Mikah has accordingly ceased operating"
21 hours...
*couldn't* care less
I bought a Lamborghini in 2019 after Nasrat promised we'd be on the Nasdaq AND in Dollar Land during that year.
Lamborghini was repossessed in 2020 after I couldn't make the payments.
So I'm supposed to actually believe Nasrat this time around?
Could just check the iBox I created.
Good grief...
2017 - Nasdaq in 2 YEARS !!!!!!!!!!!!!!!!!! per the CEO
2019 - No Nasdaq as promised (2 year mark)
2020 - Still no Nasdaq
2021 - Still no Nasdaq
2022 - Still no Nasdaq
2023 - Still no Nasdaq
2024 - Still no Nasdaq (so far)
Da fuq is you talkin' about?
No Nasdaq, No Proper Valuation.
Lol.
Just wait for the buyout...
They can't figure it out you dumbphuck.
Maybe in the summer or fall things will change but we'll have to wait and see.
The Rat 🐀 said Mikah "ceased operating" since 2015.
Oh wait...
You send WeeZuhl's post to Dianne yet?
Shhhh.....🤫
Nasrat won't tell ya.
Even you secretly know we're gonna get PHUCKED.